Clinical efficacy of compound thrombosis capsule combined with compound anisodine injection in the treatment of non-proliferative diabetic retinopathy
10.3969/j.issn.1005-1678.2017.06.065
- VernacularTitle:复方血栓通胶囊口服联合复方樟柳碱注射液局部注射治疗非增生型糖尿病视网膜病变的临床疗效
- Author:
Xuecheng SHEN
- Keywords:
compound Xueshuantong capsule;
compound anisodine injection;
local injection;
non-proliferative diabetic retinopathy;
clinical efficacy
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):175-176
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy of compound Xueshuantong capsule combined with compound anisodine injection in the treatment of non-proliferative diabetic retinopathy.MethodsSixty patients with non-proliferative diabetic retinopathy were enrolled in this study.All patients were enrolled from March 2014 to May 2016 and were divided into two groups by simple randomization.The control group were treated with salvia miltiorrhiza injection, and the patients were treated with compound Xueshuantong capsule combined with compound anisodine injection.The clinical efficacy and the level of hemorheology were compared.ResultsThe clinical improvement rate was 93.33% in the observation group, which was significantly higher than that in the control group (P<0.05).The PV, HCT, KAI and Fg levels in the observation group were significantly lower than those in the control group (P<0.05).ConclusionCompound Xueshuantong Capsule combined with compound anisodine injection for local injection of non-proliferative diabetic retinopathy has a significant clinical effect and is widely used.
